Episode 49 — October 2018

JurisDiction — The International Intellectual Property Law Podcast by Bereskin & Parr LLP

Oct 27, 2018Business

Christopher Loh of Fitzpatrick Cella Harper & Scinto in New York City discusses the Amgen v. Sanofi CAFC decision and his paper “End of ‘well characterized antigen’ test?” (Length: 20:08) Download MP3

Related Episodes

Continue listening to more episodes from JurisDiction — The International Intellectual Property Law Podcast.

Episode 53 — April 2019

Apr 16, 2019

David Pekarek Krohn and Danielle Grant-Keane of Perkins Coie LLP discuss “The Coming Wave – Preparing for...

Episode 52 — February 2019

Mar 21, 2019

Johannes Hsu of Orrick, Herrington & Sutcliffe LLP in Irvine, California discusses the Tabaian v. In...

Episode 51 — November 2018

Nov 30, 2018

Dr. Sarah Kagan of Banner & Witcoff in Washington D.C. discusses “Patent Wars: Genome Editing&...

Episode 50 — November 2018

Nov 30, 2018

Eric Ball and Athul Acharya of Fenwick & West discuss their article “Honey Badger Don’t Care,...

Episode 48 — September 2018

Sep 16, 2018

Linda Wadler and Alissa Lipton of Finnegan discuss the SCOTUS decision in WesternGeco v. Ion Geophysical...

Episode 47 — April 2018

Aug 9, 2018

Don Cameron of Bereskin & Parr LLP and Jerry Chen of JZC Intellectual Property Law discuss their inv...

Episode 46 — January 2018

Feb 11, 2018

Prof. Ben Alarie of BlueJ Legal on “Using Machine Learning to Predict Legal Outcomes”. (Length: 43:19) Do...

Episode 45 — July 2017

Aug 12, 2017

Micheline Gravelle, Don MacOdrum, Mike Fenwick and Don Cameron of Bereskin & Parr LLP discuss “The P...